MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

August 09, 2017

More than 32,000 people who fled the Kasaï region in the Democratic Republic of Congo have settled in a series of camps in northern Angola.

October 25, 2016

South Africa has one of the highest burdens of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in the world, with more than 20,000 people diagnosed with DR-TB in 2015. Yet the current DR-TB treatment regimen—which consists of a combination of multiple pills and daily injections—is only successful in about half of all people who receive it. New drugs such as delamanid offer the opportunity to provide more successful, tolerable treatment regimens to patients with few other options available.

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

August 16, 2016

Amidst an ongoing yellow fever epidemic in the Democratic Republic of Congo, Doctors Without Borders/Médecins Sans Frontières (MSF) is mobilizing considerable resources to support the Congolese authorities in a massive vaccination campaign against the disease. The plan is to vaccinate 10.5 million people over the next ten days.

July 19, 2016

Durban, South Africa—Global HIV/AIDS leaders at the International AIDS Conference in Durban must develop and implement an action plan to address the critical lack of access to HIV treatment in countries in West and Central Africa where coverage remains below 30 percent, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Tuesday.

May 31, 2016

An outbreak of yellow fever has been ravaging Angola since December 2015, raising fears that the virus could spread to other countries. The limited available stocks of vaccines constitute a particular challenge. Here, Doctors Without Borders/Médecins Sans Frontières (MSF) epidemiologist Michel Van Herp provides an update on the situation.

May 31, 2016

Doctors Without Borders/Médecins Sans Frontières (MSF) is fighting an outbreak of mosquito-borne yellow fever in southwestern Democratic Republic of Congo (DRC). Here, MSF entomologist André Yebakima explains why eliminating the insects is an important step towards eliminating the outbreak.

May 31, 2016

In Democratic Republic of Congo (DRC), Doctors Without Borders/Médecins Sans Frontières (MSF) is vaccinating the entire population of the city of Matadi, while mosquito treatment and yellow fever vector control activities are under way in Kinshasa and in Kongo Central Province. In Angola, MSF supports the Ministry of Health in treating patients.

April 20, 2016

Globally, the years 2000 to 2015 saw the scaling-up of access to antiretroviral therapy (ART), with a 35 percent decrease in AIDS-related deaths since 2005. A record number of almost 16 million people living with HIV (PLHIV) have been initiated on ART as of mid-2015, three in four of whom live in sub-Saharan Africa, where the needs are most acute. Civil society and public health services alike have rallied to bring new evidence-based treatments and best practices to PLHIV.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

Pages

August 09, 2017

More than 32,000 people who fled the Kasaï region in the Democratic Republic of Congo have settled in a series of camps in northern Angola.

October 25, 2016

South Africa has one of the highest burdens of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in the world, with more than 20,000 people diagnosed with DR-TB in 2015. Yet the current DR-TB treatment regimen—which consists of a combination of multiple pills and daily injections—is only successful in about half of all people who receive it. New drugs such as delamanid offer the opportunity to provide more successful, tolerable treatment regimens to patients with few other options available.

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

August 16, 2016

Amidst an ongoing yellow fever epidemic in the Democratic Republic of Congo, Doctors Without Borders/Médecins Sans Frontières (MSF) is mobilizing considerable resources to support the Congolese authorities in a massive vaccination campaign against the disease. The plan is to vaccinate 10.5 million people over the next ten days.

July 19, 2016

Durban, South Africa—Global HIV/AIDS leaders at the International AIDS Conference in Durban must develop and implement an action plan to address the critical lack of access to HIV treatment in countries in West and Central Africa where coverage remains below 30 percent, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Tuesday.

May 31, 2016

An outbreak of yellow fever has been ravaging Angola since December 2015, raising fears that the virus could spread to other countries. The limited available stocks of vaccines constitute a particular challenge. Here, Doctors Without Borders/Médecins Sans Frontières (MSF) epidemiologist Michel Van Herp provides an update on the situation.

May 31, 2016

Doctors Without Borders/Médecins Sans Frontières (MSF) is fighting an outbreak of mosquito-borne yellow fever in southwestern Democratic Republic of Congo (DRC). Here, MSF entomologist André Yebakima explains why eliminating the insects is an important step towards eliminating the outbreak.

May 31, 2016

In Democratic Republic of Congo (DRC), Doctors Without Borders/Médecins Sans Frontières (MSF) is vaccinating the entire population of the city of Matadi, while mosquito treatment and yellow fever vector control activities are under way in Kinshasa and in Kongo Central Province. In Angola, MSF supports the Ministry of Health in treating patients.

April 20, 2016

Globally, the years 2000 to 2015 saw the scaling-up of access to antiretroviral therapy (ART), with a 35 percent decrease in AIDS-related deaths since 2005. A record number of almost 16 million people living with HIV (PLHIV) have been initiated on ART as of mid-2015, three in four of whom live in sub-Saharan Africa, where the needs are most acute. Civil society and public health services alike have rallied to bring new evidence-based treatments and best practices to PLHIV.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

Pages